35 Crosby Drive
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of innovative imaging technology for digital radiography and breast imaging applications. Hologic's core business units are focused on mammography and breast biopsy, osteoporosis assessment and mini C-arm and extremity MRI imaging for orthopedic applications.
563 articles with Hologic
Hologic’s Cynosure Division Announces Presentation of 19 Scientific Abstracts at the American Society for Laser Medicine & Surgery’s 39th Annual Conference
Hologic, Inc.’s (Nasdaq: HOLX) Cynosure division announced today it will partner with key opinion leaders to present 19 scientific abstracts on its industry-leading medical aesthetics technology at the 39th Annual Conference of the American Society for Laser Medicine & Surgery (ASLMS).
Hologic Applauds FDA’s Proposed Rule to Update Mammography Regulations Issued Under the Mammography Quality Standards Act (MQSA) of 1992
Hologic, Inc. (Nasdaq: HOLX), the world leader in breast cancer screening technology and the company behind the Genius™ 3D Mammography™ exam, applauds the U.S. Food and Drug Administration’s proposed rule updating its regulations issued under the Mammography Quality Standards Act (MQSA) of 1992.
Women’s health company offers new training facility for partners, healthcare professionals and employees
Hologic, Inc. announced that the Company will present at these upcoming investor conferences:
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal first quarter ended December 29, 2018.
New Hologic Assay is First and Only FDA-Cleared Diagnostic Test to Detect Emerging Health Threat Mycoplasma genitalium
FDA clearance makes clinically validated assay available for sexually-transmitted infection listed as emerging threat by the CDC
Hologic to Announce Financial Results for the First Quarter of Fiscal 2019 on Wednesday, January 30, 2019
In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Hologic, Inc. announced that the Company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 8, 2019 at 11:30 a.m. Pacific Time (PT)
Medical aesthetics manufacturer also reintroduces TempSure™ Vitalia hand piece and continues to market MonaLisa Touch® laser
Hologic, Inc. (Nasdaq: HOLX) announced today that a Massachusetts Superior Court granted a preliminary injunction in lawsuits against Chinese X-ray equipment provider Direct Digital Imaging Technology (Beijing), Inc. (DDIT) and a former Hologic employee, Lawrence Ibbetson, for alleged misappropriation of trade secrets.
Flexible, modular design with powerful visualization gives doctors a single device with three sheath options to both diagnose and treat patients
Future-focused breast health leader will highlight recent advancements with interactive booth experiences, workshops and symposia
Hologic, Inc. announced today that Ludwig N. Hantson has been elected to the Company’s Board of Directors, effective immediately.
Hologic, Inc. announced today that the Company will present at the 30th Annual Piper Jaffray Healthcare Conference in New York, NY on Wednesday, November 28 at 8 a.m. Eastern Time.
– Revenue of $813.5 Million Grows 1.3%, 1.7% in Constant Currency –
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2018 on Wednesday, November 7, 2018
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2018 on Wednesday, November 7, 2018, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Hologic Survey Reveals More than Three in Five Women are Unaware that the Density of a Woman's Breasts Impacts Her Risk for Developing Breast Cancer
Survey commissioned by Company behind the Genius™ 3D Mammography™ exam sheds light on need for education during Breast Cancer Awareness Month
Hologic CEO Steve MacMillan to be Joined by Susan G. Komen Founder Nancy Brinker and Pink Hope Founder Krystal Barter to Ring Nasdaq Opening Bell on October 1
World leader in breast cancer screening celebrates start of Breast Cancer Awareness Month, releases new survey results on breast density
New Technology Simplifies and Streamlines Fluid Management for Doctors and Nurses
Hologic's Cynosure Division Signs Agreement with Porter Instrument to Exclusively Distribute Nitrous Oxide and Oxygen System in Aesthetics Market
Hologic, Inc. (Nasdaq: HOLX) today announced completion of an agreement between its Cynosure division and Porter Instrument, a business unit of Parker Hannifin Corporation, for distribution rights in the United States and Canada to Porter Instrument's nitrous oxide and oxygen system, Nitronox™.